The approval of the Roundup ingredient follows an extensive debate amidst conflicting evidence over the health effects of the world’s most popular weed killer. After a year teaching an algorithm to ...
9d
Pharmaceutical Technology on MSNEC approves Otsuka and Lundbeck’s Rxulti for schizophreniaThe decision was supported by a randomised, six-week, placebo-controlled trial involving 316 adolescent subjects.
13d
GlobalData on MSNEC approves BMS’ Opdivo and Yervoy combo for HCCThe European Commission (EC) has granted approval for Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) in combination with the ...
The European Commission (EC) set out plans to make €100 billion available to support eco-friendly manufacturing of technology, as part of its Clean Industrial Deal (CID) which aims to cut red tape and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results